Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score

scientific article published on June 2015

Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/EURHEARTJ/EHV194
P698PubMed publication ID26033984

P50authorMichael BaileyQ41130860
David PilcherQ46110243
Carol L. HodgsonQ48311327
David J. CooperQ57070884
Daniel BrodieQ87827918
Vincent PellegrinoQ88255248
Ravi R ThiagarajanQ88264561
Matthieu SchmidtQ114573983
Carlos ScheinkestelQ117259428
Jayne SheldrakeQ117259432
Peter T RycusQ117259437
P2093author name stringLloyd Roberts
Aidan Burrell
P433issue33
P921main subjectextracorporeal membrane oxygenationQ1385195
cardiogenic shockQ2477062
P304page(s)2246-2256
P577publication date2015-06-01
P1433published inEuropean Heart JournalQ2286839
P1476titlePredicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score
P478volume36

Reverse relations

cites work (P2860)
Q346773472016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib
Q90243596A Simple Scoring System to Predict Survival after Venoarterial Extracorporeal Membrane Oxygenation
Q39695029A local network for extracorporeal membrane oxygenation in refractory cardiogenic shock
Q33581752Advanced Age as a Predictor of Survival and Weaning in Venoarterial Extracorporeal Oxygenation: A Retrospective Observational Study
Q94482870Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-A "Living Working Document"
Q56381075Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology
Q88527382Advances in critical care management of patients undergoing cardiac surgery
Q47283268Ambulatory central VA-ECMO with biventricular decompression for acute cardiogenic shock
Q64248937An audit of mortality by using ECMO specific scores and APACHE II scoring system in patients receiving extracorporeal membrane oxygenation in a tertiary intensive care unit in Hong Kong
Q56893227Associations between ventilator settings during extracorporeal membrane oxygenation for refractory hypoxemia and outcome in patients with acute respiratory distress syndrome: a pooled individual patient data analysis : Mechanical ventilation during E
Q38633582Cardiac surgery score (CASUS) improves outcome prediction in patients treated with extracorporal life support (ECLS).
Q94503860Cardiovascular Collapse in COVID-19 Infection: The Role of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO)
Q90294961Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis
Q93027580Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial
Q92280780Clinical Efficacy of Extracorporeal Cardiopulmonary Resuscitation for Adults with Cardiac Arrest: Meta-Analysis with Trial Sequential Analysis
Q54979160Clinical determinants of successful weaning from extracorporeal membrane oxygenation in patients with fulminant myocarditis.
Q64267162Clinical implications of the initial SAPS II in veno-arterial extracorporeal oxygenation
Q39317396Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock
Q55000890Cost-effectiveness in extracorporeal life support in critically ill adults in the Netherlands.
Q37684248Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the Extracorporeal Life Support Organization (ELSO) registry.
Q37205892ECMO Used in a Refractory Ventricular Tachycardia and Ventricular Fibrillation Patient: A National Case-Control Study
Q37639744ECMO in cardiac arrest and cardiogenic shock
Q89420903ECMO use and mortality in adult patients with cardiogenic shock: a retrospective observational study in U.S. hospitals
Q60950116ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period
Q37717673Early Prediction of 3-month Survival of Patients in Refractory Cardiogenic Shock and Cardiac Arrest on Extracorporeal Life Support.
Q57126169Early enteral nutrition for cardiogenic or obstructive shock requiring venoarterial extracorporeal membrane oxygenation: a nationwide inpatient database study
Q90470639Effect of interplay between age and low-flow duration on neurologic outcomes of extracorporeal cardiopulmonary resuscitation
Q95940938Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock - A position statement from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Q42545181External Validation of Survival-Predicting Models for Acute Myocardial Infarction with Extracorporeal Cardiopulmonary Resuscitation in a Chinese Single-Center Cohort.
Q96135076Extra-corporeal membrane oxygenation and Eculizumab: Atypical treatments for typical haemolytic uraemic syndrome
Q98386253Extra-corporeal membrane oxygenation for severe respiratory failure in the UK
Q94482874Extracorporeal Life Support Organization COVID-19 Interim Guidelines
Q26746652Extracorporeal Membrane Oxygenation as a Bridge for Heart Failure and Cardiogenic Shock
Q94554077Extracorporeal Membrane Oxygenation in Cardiogenic Shock due to Acute Myocardial Infarction: A Systematic Review
Q28071264Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis
Q47653181Extracorporeal life support in cardiogenic shock: indications and management in current practice.
Q48149565Extracorporeal membrane oxygenation for poisoning in adult patients: outcomes and predictors of mortality
Q37646693Extracorporeal membrane oxygenation support in post-traumatic cardiopulmonary failure: A 10-year single institutional experience
Q92008484Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic
Q47108069Factors Associated with the Need for, and the Impact of, Extracorporeal Membrane Oxygenation in Children with Congenital Heart Disease during Admissions for Cardiac Surgery.
Q47133334Impact of dynamic changes of elevated bilirubin on survival in patients on veno-arterial extracorporeal life support for acute circulatory failure
Q64120125Important methodological flaws in the recently published clinical prediction model the REMEMBER score
Q57399045In Reply
Q36765684In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5,263 patients using a national inpatient database in Japan
Q61804720Interprofessional two-man team approach for interhospital transport of ARDS-patients under extracorporeal membrane oxygenation: a 10 years retrospective observational cohort study
Q37208712Is there light at the end of the tunnel?-new perspectives in ECMO survival.
Q87994316Isolated left ventricular failure is a predictor of poor outcome in patients receiving veno-arterial extracorporeal membrane oxygenation
Q37724757Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation
Q33363257Liver function during mechanical circulatory support: from witness to prognostic determinant
Q91607128Long-term survival and costs following extracorporeal membrane oxygenation in critically ill children-a population-based cohort study
Q38648838Mechanical Circulatory Support for Decompensated Heart Failure
Q64231056Mechanical Circulatory Support in the Cardiac Catheterization Laboratory for Cardiogenic Shock
Q30826381Microcirculatory assessment of patients under VA-ECMO.
Q93198462Model-Based Weaning Tests for VA-ECLS Therapy
Q90141233Mortality and costs following extracorporeal membrane oxygenation in critically ill adults: a population-based cohort study
Q65002854National trends and outcomes for extra-corporeal membrane oxygenation use in high-risk pulmonary embolism.
Q93190062Neonatal Cardiac ECMO in 2019 and Beyond
Q38694158Noteworthy Articles in 2015 for Cardiothoracic Critical Care
Q46125420Novel prediction tool for veno-arterial extracorporeal membranous oxygenation in acute myocardial infarction patients.
Q26770310Options for temporary mechanical circulatory support
Q39017618Outcome of elderly undergoing extracorporeal life support in refractory cardiogenic shock
Q54964671Outcomes in Cardiogenic Shock Patients with Extracorporeal Membrane Oxygenation Use: A Matched Cohort Study in Hospitals across the United States.
Q64251627Outcomes of venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock: systematic review and meta-analysis
Q46276325Pediatric Extracorporeal Life Support Organization Registry International Report 2016.
Q49950489Position paper for the organization of ECMO programs for cardiac failure in adults
Q38631238Postoperative management of heart failure in pediatric patients
Q64245580Predicting clinical outcome in patients undergoing VA-ECMO
Q90428437Predicting mortality after postcardiotomy venoarterial extracorporeal membrane oxygenation
Q60911598Predicting mortality in patients undergoing VA-ECMO after coronary artery bypass grafting: the REMEMBER score
Q57479596Predictors of Survival for Patients with Acute Decompensated Heart Failure Requiring Extra-Corporeal Membrane Oxygenation Therapy
Q97537997Predictors of survival following veno-arterial extracorporeal membrane oxygenation in patients with acute myocardial infarction-related refractory cardiogenic shock: clinical and coronary angiographic factors
Q38600946Prognostic indicators of survival and survival prediction model following extracorporeal cardiopulmonary resuscitation in patients with sudden refractory cardiac arrest.
Q88711670Shock Management for Cardio-surgical Intensive Care Unit Patient: The Silver Days
Q98466838Short-term mechanical circulatory support (intra-aortic balloon pump, Impella, extracorporeal membrane oxygenation, TandemHeart): a review
Q47338687Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock.
Q91644956Temporary Mechanical Circulatory Support in Acute Heart Failure
Q97589339Temporary circulatory support for cardiogenic shock
Q40042007The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock
Q64251633The Extracorporeal Life Support Organization Registry: update and perspectives
Q30234573The ICM research agenda on extracorporeal life support
Q39799745The Impact of Renal Failure and Renal Replacement Therapy on Outcome During Extracorporeal Membrane Oxygenation Therapy
Q47552207The Initial Evaluation and Management of a Patient with Heart Failure
Q42041408The Need for Extracorporeal Membrane Oxygenation in Adults Undergoing Congenital Heart Surgery: Impact and Trends of Utilization.
Q58707960The Role of Echocardiography in Neonates and Pediatric Patients on Extracorporeal Membrane Oxygenation
Q30491215The challenges in predicting ECMO survival, and a path forward
Q47415870The impact of severity of initial illness, determined by SOFA score, and presence of anemia on outcomes among patients requiring Extra Corporal Membrane Oxygenation (ECMO) support: A single center experience
Q39261028The modified SAVE score: predicting survival using urgent veno-arterial extracorporeal membrane oxygenation within 24 hours of arrival at the emergency department
Q92158475Therapeutic Advances in the Management of Cardiogenic Shock
Q55412673Vascular complications in adult postcardiotomy cardiogenic shock patients receiving venoarterial extracorporeal membrane oxygenation.
Q47278862Veno-arterial extracorporeal membrane oxygenation in addition to primary PCI in patients presenting with ST-elevation myocardial infarction
Q39342710Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock post-cardiac arrest
Q36653630Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome in Adults: Prognostic Factors for Outcomes
Q42332758What is extracorporeal cardiopulmonary resuscitation?

Search more.